Drug target validation and identification of secondary drug target effects using DNA microarrays
Nature Medicine1998Vol. 4(11), pp. 1293–1301
Citations Over TimeTop 1% of 1998 papers
Matthew J. Marton, Joseph L. DeRisi, Holly A. Bennett, Vishwanath R. Iyer, Michael R. Meyer, Christopher J. Roberts, Roland Stoughton, Julja Burchard, David Slade, Hongyue Dai, Douglas E. Bassett, Leland H. Hartwell, Patrick O. Brown, Stephen Friend
Related Papers
- → AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders(2023)36 cited
- → Drug-Target Interactions: Prediction Methods and Applications(2016)41 cited
- → Drug Repurposing: A Review(2021)9 cited
- → Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19(2022)8 cited
- → P62 SIMPATHIC: accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology(2023)